Brilliant blue g
Tissueblue (brilliant blue g) is a small molecule pharmaceutical. Brilliant blue g was first approved as Tissueblue on 2019-12-20. It is known to target P2X purinoceptor 7.
| Trade Name | Tissueblue |
|---|---|
| Common Name | Brilliant blue g |
| Indication | |
| Drug Class |
